• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B细胞型慢性淋巴细胞白血病(B-CLL)与意义未明的单克隆B淋巴细胞增多症(B-MLUS)之间血液T细胞和自然杀伤(NK)细胞群体的差异。

Differences in blood T and NK cell populations between chronic lymphocytic leukemia of B cell type (B-CLL) and monoclonal B-lymphocytosis of undetermined significance (B-MLUS).

作者信息

Kimby E, Mellstedt H, Nilsson B, Björkholm M, Holm G

机构信息

Department of Medicine, Danderyd Hospital, Sweden.

出版信息

Leukemia. 1989 Jul;3(7):501-4.

PMID:2471902
Abstract

T and NK cell blood subpopulations were determined in 33 patients with B-CLL and in 14 patients with B-MLUS by two-color immunofluorescence. CLL patients had significantly higher total numbers of Leu-7+ and CD8+ cells and lower numbers of CD16+/Leu-7- cells as well as a higher Leu-7/CD16 ratio and a lower CD4/CD8 ratio than MLUS patients and control donors. Moreover, MLUS patients exhibited a significantly lower Leu-7/CD16 ratio as well as a higher frequency of CD16+/Leu-7- cells than healthy donors. These results suggest that B-CLL patients have higher numbers of circulating immature NK cells compared to B-MLUS, while B-MLUS patients have a larger proportion of NK cells with a high lytic capability as compared to both CLL and normal controls. The imbalance between CD4+ and CD8+ cells was prominent in CLL with a low CD4/CD8 ratio, but within the upper normal range in MLUS. Differences in immunoregulatory cell subpopulations between B-CLL and B-MLUS might therefore contribute to the different clinical behavior of these two disorders.

摘要

通过双色免疫荧光法测定了33例B细胞慢性淋巴细胞白血病(B-CLL)患者和14例B细胞单克隆淋巴细胞增多症(B-MLUS)患者的T细胞和NK细胞血液亚群。与B-MLUS患者及对照供者相比,CLL患者的Leu-7+和CD8+细胞总数显著更高,CD16+/Leu-7-细胞数量更低,Leu-7/CD16比值更高,CD4/CD8比值更低。此外,与健康供者相比,B-MLUS患者的Leu-7/CD16比值显著更低,CD16+/Leu-7-细胞频率更高。这些结果表明,与B-MLUS相比,B-CLL患者循环中未成熟NK细胞数量更多,而与CLL和正常对照相比,B-MLUS患者具有高裂解能力的NK细胞比例更大。CLL患者中CD4+和CD8+细胞之间的失衡较为突出,CD4/CD8比值较低,但在B-MLUS中处于正常上限范围内。因此,B-CLL和B-MLUS之间免疫调节细胞亚群的差异可能导致这两种疾病不同的临床行为。

相似文献

1
Differences in blood T and NK cell populations between chronic lymphocytic leukemia of B cell type (B-CLL) and monoclonal B-lymphocytosis of undetermined significance (B-MLUS).B细胞型慢性淋巴细胞白血病(B-CLL)与意义未明的单克隆B淋巴细胞增多症(B-MLUS)之间血液T细胞和自然杀伤(NK)细胞群体的差异。
Leukemia. 1989 Jul;3(7):501-4.
2
Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia (B-CLL) as compared to monoclonal B-cell lymphocytosis of undetermined significance (B-MLUS).与意义未明的单克隆B淋巴细胞增多症(B-MLUS)相比,B细胞慢性淋巴细胞白血病(B-CLL)中T细胞失衡和生长因子受体表达更高。
Leuk Res. 1989;13(1):31-7. doi: 10.1016/0145-2126(89)90028-3.
3
CD4, CD8 and NK subsets in B-CLL.B淋巴细胞慢性淋巴细胞白血病中的CD4、CD8和自然杀伤细胞亚群
Nouv Rev Fr Hematol (1978). 1988;30(5-6):331-4.
4
Clonal cell surface structures related to differentiation, activation and homing in B-cell chronic lymphocytic leukemia and monoclonal lymphocytosis of undetermined significance.与B细胞慢性淋巴细胞白血病及意义未明的单克隆淋巴细胞增多症中的分化、激活和归巢相关的克隆性细胞表面结构。
Eur J Haematol. 1989 Nov;43(5):452-9. doi: 10.1111/j.1600-0609.1989.tb00335.x.
5
CD5-negative phenotype of monoclonal B-lymphocytosis of undetermined significance (MLUS).
Am J Hematol. 2002 Feb;69(2):147-9. doi: 10.1002/ajh.10044.
6
The leukemic B-cell population of patients with monoclonal lymphocytosis of undetermined significance (MLUS) are functionally distinct from the chronic lymphocytic leukemia (CLL) derived cell population.意义未明的单克隆淋巴细胞增多症(MLUS)患者的白血病B细胞群体在功能上与慢性淋巴细胞白血病(CLL)衍生的细胞群体不同。
Leuk Res. 1991;15(8):715-9. doi: 10.1016/0145-2126(91)90074-4.
7
Differentiation of monoclonal B lymphocytosis of undetermined significance (MLUS) and chronic lymphocytic leukemia (CLL) with weak CD5 expression from CD5(-) CLL.意义未明的单克隆B淋巴细胞增多症(MLUS)与CD5表达较弱的慢性淋巴细胞白血病(CLL)与CD5(-) CLL的鉴别。
Leuk Res. 2002 Dec;26(12):1125-9. doi: 10.1016/s0145-2126(02)00062-0.
8
Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.单克隆B细胞淋巴细胞增多症与慢性淋巴细胞白血病
N Engl J Med. 2008 Aug 7;359(6):575-83. doi: 10.1056/NEJMoa075290.
9
Serum levels of helper factors (IL-1 alpha, IL-1 beta and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and beta 2-microglobulin in patients with B-CLL and benign B lymphocytosis.B细胞慢性淋巴细胞白血病和良性B淋巴细胞增多症患者血清中辅助因子(IL-1α、IL-1β和IL-6)、T细胞产物(sCD4和sCD8)、可溶性白细胞介素-2受体和β2-微球蛋白的水平。
Leuk Res. 1992 Jun-Jul;16(6-7):607-13. doi: 10.1016/0145-2126(92)90009-v.
10
The absence of correlation between immunoregulatory T cells and induced lymphoproliferative response in treated B-chronic lymphocytic leukemia patients.
Panminerva Med. 1999 Jun;41(2):93-7.

引用本文的文献

1
Natural Killer Cells in Chronic Lymphocytic Leukemia: Functional Impairment and Therapeutic Potential.慢性淋巴细胞白血病中的自然杀伤细胞:功能损害与治疗潜力
Cancers (Basel). 2022 Nov 24;14(23):5787. doi: 10.3390/cancers14235787.
2
Expression of natural killer cell activating receptors in patients with chronic lymphocytic leukaemia.自然杀伤细胞激活受体在慢性淋巴细胞白血病患者中的表达。
Immunology. 2012 Feb;135(2):151-7. doi: 10.1111/j.1365-2567.2011.03521.x.
3
Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia.
呼吸道感染与慢性淋巴细胞白血病的后续风险
Blood. 2007 Mar 1;109(5):2198-201. doi: 10.1182/blood-2006-08-044008. Epub 2006 Nov 2.
4
Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia (B-CLL): comparison of indolent and progressive disease.B 细胞慢性淋巴细胞白血病(B-CLL)患者 T 细胞中的信号分子与细胞因子产生:惰性疾病与进展性疾病的比较
Med Oncol. 2005;22(3):291-302. doi: 10.1385/MO:22:3:291.
5
Immunologic monitoring in chronic lymphocytic leukemia.慢性淋巴细胞白血病的免疫监测
Curr Oncol Rep. 2003 Sep;5(5):419-25. doi: 10.1007/s11912-003-0029-3.
6
Growth and survival of B-chronic lymphocytic leukaemia cells.B 细胞慢性淋巴细胞白血病细胞的生长与存活
Med Oncol. 1998 Jul;15(2):73-8. doi: 10.1007/BF02989583.